Mouse Models
Six-to 8-week-old C57B6 female mice (n = 100) were purchased from the National Cancer Institute (Bethesda, MD). All mice were housed and treated in accordance with the guidelines of The University of Texas MD Anderson Cancer Center ' s Institutional Animal Care and Use Committee.
To examine whether K1 interferes with Fas-mediated apoptosis induced by agonistic anti-Fas antibody in vivo, mice were transfected with 100 µ g of pCDEF or pCDEFFlag-K1 plasmid by rapid injection into the tail vein in a single dose ( 14 ) . Because the transfection procedure led to random early deaths of 5 of 15 pCDEFtransfected and of 1 of 15 pCDEFFlag-K1 -transfected mice, we could not enforce equal numbers of mice in each group. At 24 hours after transfection, apoptosis was induced in all surviving mice by intravenous injection of a lethal dose of agonistic monoclonal anti-mouse Fas antibody Jo2 (400 ng/g of mouse weight; BD Pharmingen, San Jose, CA). Three additional mice were transfected with pCDEFFlag-K1 plasmid to evaluate the effect of K1 expression on the apoptosis of the livers in the absence of the agonistic Fas antibody challenge. To examine whether K1 interferes with Fas-mediated apoptosis induced by recombinant Fas ligand (FasL) in vivo, mice were transfected with 100 µ g of pCDEF (n = 10) or pCDEFFlag-K1 plasmid (n = 10), and apoptosis was induced 24 hours later by injection with Flag-tagged recombinant FasL (4 µ g per mouse; Axxora, LLC, San Diego, CA) alone (n = 5 per group) or together with cross-linking mouse monoclonal antiFlag antibody M2 (n = 5 per group; 12.5 µ g/mouse; Stratagene).
For 6 -7 hours after treatment, mice were monitored for survival, just after which surviving mice were killed by inhalation of 100% CO 2 , and the livers of all mice were surgically removed. This time point was predefi ned, because all treated mice were expected to die by 6 hours after treatment, based on previous fi ndings ( 20 , 21 ) ; thus, this was the optimal time to assay apoptosis and liver damage as possible mechanisms of mortality. Removed livers were divided in two parts, which were either frozen for later homogenization for immunoprecipitation and Western blot analysis or embedded in paraffi n for immunostaining.
To evaluate the relative contribution of K1 Ig -like domain and ITAM domain to protection from Fas-mediated apoptosis, mice were transfected with a vector control (n = 14) or with plasmids expressing Flag-tagged full-length K1 (K1-Flag; n = 10), Flag-tagged K1 mutant lacking the Ig-like domain (K1 ⌬ Ig-Flag; n = 6), or Flag-tagged K1 mutant lacking the ITAM domain (K1m-Flag; n = 6). One of the 14 vector-transfected and 2 of the 6 K1m-transfected mice died as a result of the transfection procedure. All surviving mice were treated 24 hours after transfection with agonistic Fas antibody Jo2 (400 ng/g of weight) and monitored for survival for up to 6 hours after treatment and then killed for harvesting of liver tissue as described above.
CONTEXT AND CAVEATS

Prior knowledge
Herpesvirus 8 oncoprotein K1 has a role in Fas death receptormediated proliferation of cells in the lymph nodes and suppression of cell death , and its expression in transgenic mice leads to lymphoma.
Study design
K1 -Fas binding and cell death were assayed after treatment with Fas ligand (FasL) or agonistic Fas antibody in cell lines that expressed wild-type K1 or an Ig domain deletion mutant. Survival of mice transfected with wild-type K1 or an Ig domain deletion mutant after treatment with agonistic Fas antibody.
Contributions
Wild-type K1 but not the Ig domain deletion mutant binds to Fas and inhibits its activation by FasL or agonistic Fas antibody. Wildtype K1 but not the mutant increased the survival of mice treated with agonistic Fas antibody.
Implications
The Ig domain of K1 is essential to Fas binding and inhibition.
Limitations
Whether these interactions occur in vivo in cells that are infected with the virus is unknown. The protein interactions observed could have been nonspecific interactions that were driven by overexpression of the K1 protein.
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To evaluate the effi ciency of the transfection method, three mice were transfected with 100 µ g of either PCDNA, pCDNA-EGFP, or pCDNA-CD74-EGFP plasmid. Twenty-four hours after transfection, mice were killed by inhalation of 100% CO 2 . Livers were surgically removed and viewed using a Zeiss Axioskop 2 plus fl uorescence microscope (Carl Zeiss, Thornwood, NY) at ×20 magnifi cation using standard fi lters for observation of enhanced green fl uorescent protein (EGFP) fl uorescence.
To evaluate formation of K1 -Fas complexes in the mouse livers, mice were transfected with pLJP8 (which express K1 strain A), pLJP15 (which express Flag-tagged K1 strain A), or pLJP16 (which express Flag-tagged K1 strain B) plasmids (n = 3 per group). Twenty-four hours after transfection, mice were killed and their livers were surgically removed and homogenized for immunoprecipitation and Western blot analysis.
Cells, Transfections, and Induction of Apoptosis HEK 293 cells (from the National Institutes of Health AIDS Research and Reference Reagent Program, Bethesda, MD) were grown in Dulbecco's modified Eagle Medium (GIBCO/Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT) in a 5% CO 2 atmosphere at 37°C. Cells were passaged 1:3 every 3 days after a brief treatment with trypsin-EDTA.
Human lymphoma BJAB cells (American Type Culture Collection, Manassas, VA) and BJABXS, BJABK1, and BJABK1m cells, which stably express empty vector, full-length K1, and K1 lacking the ITAM domain, respectively, as previously described ( 13 ) were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum, 50 U/mL penicillin, 50 µ g/mL streptomycin, and 2 mM l -glutamine (all from GIBCO/Invitrogen). Experiments were performed using early passage cells (p5 -p15) obtained from commercial source who confi rmed the identity of the cells.
HEK 293 cells in 10-cm tissue culture dishes at 50% -60% confl uency were transfected with 5 -10 µ g of the plasmids indicated in the fi gure legends using FuGENE 6 transfection reagent in accordance with manufacturer's instructions (Roche Diagnostics, Indianapolis, IN).
To evaluate the degree of apoptosis induced by FasL in K1-expressing stable BJABK1 cells and in control BJAB cells, cells were seeded into 48-well plates (1 × 10 6 /mL per well) and incubated with buffer alone (n = 3) or with 5 ng/mL (n = 3) or 10 ng/mL (n = 3) of recombinant FasL (Axxora). After a 24-hour treatment, cells were fi xed by addition of formaldehyde (4% fi nal concentration; Sigma-Aldrich, St Louis, MO) and subjected to centrifugation for 10 minutes at 500 g at 4°C to attach cells to the plate. To stain cell nuclei, cells were incubated with Hoechst blue 33342 (1:20 000; Molecular Probes, Carlsbad, CA) for 15 minutes and observed on Zeiss Axioskop 2 plus fl uorescence microscope at ×20 magnifi cation using standard fi lters for observation of 4',6-diamidino-2-phenylindole fl uorescence. Three random optical fi elds per well were used to count the total numbers of nuclei and apoptotic nuclei (nuclei with altered morphology).
Immunohistochemical Staining of Mouse Liver Tissues
Formalin-fixed, paraffin-embedded liver tissue sections on microscope slides were treated with an unmasking kit (1:500; Vector Laboratories, Burlingame, CA).
Sections were then stained with hematoxylin and eosin (both from Fisher Scientifi c, Pittsburgh, PA).
Immunohistochemical staining was performed using a mouse monoclonal anti-Flag antibody M2 (1:500; Sigma-Aldrich) and a rabbit polyclonal anti -cleaved caspase-3 antibody (1:500; Cell Signaling, Danvers, MA), followed by staining and developing with an ABC staining kit (Vector Laboratories).
Terminal deoxynucleotidyl transferase -mediated Z'-deoxyuridine S'-triphosphate nick end labeling (TUNEL) staining was performed using an APO-BRDU-IHC kit (Phoenix Flow Systems, San Diego, CA) ( 22 ) . Briefl y, liver sections were treated with proteinase K7 for 20 minutes and incubated with Br-dUTP in the presence of TdT enzyme overnight. The slides were incubated with biotinylated antiBrdU antibody, developed using avidin-biotinylated peroxidase, counterstained with Mayer hematoxylin, and fi xed in Permount (Fisher Scientifi c) according to manufacturer's recommendations.
Stained samples were viewed using a Zeiss Axioskop 2 plus microscope at ×20 magnifi cation.
Immunoprecipitation and Western Blot Analysis
Extracts of HEK 293 cells that were transfected with the indicated plasmids and extracts from livers of transfected mice were prepared in lysis buffer (1% Nonidet P-40, 50 mM HEPES [pH 7.5], 100 mM sodium chloride, 2 mM EDTA, 1 mM pyrophosphate, 10 mM sodium orthovanadate, 3 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride, 10 mM sodium fluoride, 4 µ g/mL aprotinin, and 1 µ g/mL leupeptin; all from Sigma-Aldrich) for 30 minutes on ice. The lysate solution was centrifuged at 13 000 g for 10 minutes at 4°C, and supernatants were collected. For K1 -Fas complex precipitation, 300 µ g of cell extract or 5 mg of liver protein was incubated for 1 hour at 4°C with 5 µ g of the following primary antibodies: mouse monoclonal anti-human Fas antibody B-10, mouse monoclonal anti-human Fas -activating antibody CH-11 (IgM class), rabbit polyclonal anti-mouse Fas antibody A-20, mouse monoclonal anti-myc antibody (all from Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-Flag antibody M2, goat polyclonal anti-mouse IgM antibody (both from Sigma-Aldrich), both from rat polyclonal anti-HA tag antibody, and mouse monoclonal anti-CD40 antibody (Roche Diagnostics). Protein A/G sepharose (20 µ L; Pierce Biotechnology/Thermo Scientific, Rockford, IL) was then added to the extract, and the mixture was incubated for 4 hours at 4°C. In the glutathione S-transferase (GST) pull-down assay, supernatants were collected and incubated with glutathione sepharose 4B (Amersham/GE Healthcare, Piscataway, NJ), and prewashed three times with washing buffer (50 mM Tris [pH 8.0], 300 mM NaCl, 0.5% NP-40) containing a protease inhibitor cocktail at 4°C for 3 hours. The precipitated pellets were washed five times with lysis buffer and boiled in sodium dod ecyl sulfate (SDS) -loading buffer. Proteins in supernatants were separated by electrophoresis in 10% SDS -polyacrylamide gels (Bio-Rad Laboratories, Hercules, CA) and transferred to nitrocellulose membranes (Whatman Schleicher & Schuell, Keene, NH). To cross-link protein complexes on the plasma membranes of intact HEK 293 cells transfected with pcDEF3 or pcDEF K1-Flag plasmids, cells were treated for 30 minutes before cell lysis with 10 mM 3,3 ′ -dithio-bissulfosuccinimidyl propionate (DSS) alone or in combination with 8 mM N -ethyl maleimide (NEM) to block free sulfhydryl groups as described previously ( 23 ) .
Flow Cytometry Analysis for Fas
BJABXS, BJABK1m, and BJABK1 cells (1 × 10 6 ) were washed twice with 0.1 M phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 ) + 10% FBS and subsequently incubated with allophycocyanin-conjugated monoclonal anti-Fas antibody Bu-45 (1:15; Santa Cruz Biotechnology) for 20 minutes at 4°C. After three washes with cold PBS + 10% FBS, cells were resuspended in 500 µ L of PBS + 2% FBS and analyzed using a FACS Calibur flow cytometer (BD Biosciences, Mountain View, CA) using BD CellQuest for data acquisition. Data were analyzed and plotted by using FlowJo software (Tree Star, Inc., Ashland, OR).
Statistical Analysis
All P values were calculated based on appropriate two-sided statistical tests. Fisher exact tests were used for contingency tables of mice death counts. Student t tests were used for comparing continuous variables, and Bonferroni correction was used to adjust for multiple comparisons. The percentages of apoptotic tissue culture cells were obtained from three different experiments, and the mean percentages were compared. The percentages of apoptotic cells in liver tissues were obtained from three random fields and sections per mouse, and the mean percentages were calculated for four mice per group. P values less than .050 were considered statistically significant, except when Bonferroni adjustments were made, in which case P values less than .0125 were considered statistically significant.
Results
Inhibition of Fas-Mediated Apoptosis in Livers of K1-Expressing Mice
To evaluate the degree of apoptosis in the livers of K1-expressing mice, we transfected mice with plasmids encoding K1-Flag or with empty vector using a high-efficiency transfection method ( 14 , 24 ) . Twenty-four hours later, mice were challenged with a lethal dose of agonistic Fas antibody Jo2. None of the vector-transfected mice were alive 6 hours after challenge, whereas 13 of the 14 K1-transfected mice had survived ( Figure 1 , A , P < .001). Thus, transient K1 expression in mouse livers conferred resistance to a lethal treatment with agonistic Fas antibody.
The surviving K1-transfected mice were killed 6 hours after challenge, and their liver tissues were harvested and compared with those of vector-transfected mice. The livers of the dead vector-transfected mice were swollen and hemorrhagic, with extensive extravasations of blood cells and numerous dead cells. In contrast, livers from the surviving K1-transfected mice had mostly normal appearance, minimal hemorrhaging and extravasations, and a few dead cells ( Figure 1, B ) . Staining of liver sections with anti-Flag antibody showed successful expression of K1-Flag in cells that were polygon shaped and contained centrally located nuclei (characteristics of hepatocytes), as expected using this transfection method, which targets hepatocytes with high effi ciency ( Figure 1, B ) . Immunohistochemical staining showed expression of K1 protein in about 10% -15% of cells. Livers of mice that had been transfected with plasmids expressing EGFP or EGFP fusion proteins ( Figure 1, C ) showed expression of EGFP in 70% of cells, suggesting a more widespread pattern of transgene expression than indicated by immunohistochemistry ( Figure 1, B ) . Apoptosis in livers of K1-transfected and control mice was compared by staining thin sections with anti -cleaved caspase-3 antibody and by TUNEL assay ( Figure 1, B ) . The percentage of cleaved caspase-3 -positive cells was statistically signifi cantly lower in K1-transfected mice than in vector-transfected control mice (vector vs K1: mean = 87.6% vs 58.0%, difference = 29.6%, 95% confi dence interval [CI] = 19.2% to 40.0%; P = .003). The K1-transfected mice also had fewer TUNEL-positive cells than did the control mice (vector vs K1: mean = 83.7% vs 34.2%, difference = 49.5%, 95% CI = 39.8% to 59.2%; P = .003). Thus, as clearly shown by several methods, K1 expression in nonmalignant cells in their natural in vivo setting interferes with the induction of Fas-mediated apoptosis.
Association of K1 With Fas in Transfected Cells and Livers
To determine whether K1 elicits its effect on Fas-mediated apoptosis through direct interaction with Fas, we transfected HEK 293 cells with plasmids encoding myc-tagged K1, Fas, or both, and then used Fas and myc antibodies to coimmunoprecipitate the protein complexes. The myc antibody coprecipitated Fas from cells that expressed K1-myc but not from cells that expressed Fas alone ( Figure 2, A ) . The bands that represent the proteins that were coprecipitated by myc antibodies from HEK 293 cells not transfected with Fas represent the levels of endogenous Fas in these cells ( 25 ) . K1 -Fas binding was also confirmed by expression of K1-Flag and K1-HA and by the coimmunoprecipitation of protein complexes with the corresponding tag antibodies (data not shown).
To exclude the possibility that K1 -Fas coprecipitation was due to nonspecifi c protein binding that was induced by experimental manipulations, we transfected HEK 293 cells with plasmids encoding K1-Flag or with the vector alone and treated them with a cell-impermeable cross-linker, DSS, in the presence or absence of NEM, which blocks free sulfhydryl groups. Fas antibodies readily precipitated K1-Flag in higher-molecular weight complexes ( Figure 2 , B , arrowheads), some of which were absent in non -cross-linked cells, indicating the existence of the K1 -Fas complexes at the plasma membrane before cell disruption. In extracts of DSS-treated cells, two major species were identifi ed, likely representing K1 -Fas heterodimers (approximately 85 kDa) and larger K1 -Fas complexes (>250 kDa) that may contain other proteins.
Under conditions that show K1 protection of mice from Fas-mediated apoptosis ( Figure 1 ), we probed K1-expressing liver tissues for K1 -Fas complexes. Flag-tagged K1 from two different strains of HHV-8 ( 26 ) coprecipitated with Fas ( Figure 2, C ) . From these results we concluded that K1 and Fas physically associate at the cell membrane and that K1 -Fas complexes potentially interfere with early activation of Fas in apoptosis induction.
Inhibition of FasL-Induced Apoptosis by K1
It has been suggested previously that Fas signaling in response to agonistic antibodies may differ from that in response to FasL ( 27 ) . We thus aimed to explore the interference of K1 with apoptosis induced by FasL. We first incubated control BJABXS and K1-expressing BJABK1 cells with 0, 5, and 10 ng/mL of recombinant FasL. Apoptosis was evaluated 24 hours later based on the morphology of the nuclei, as described in "Materials and Methods." The percentage of cells undergoing apoptosis that was induced by 5 and 10 ng/mL of FasL treatment was statistically significantly lower in K1-expressing cells than in control cells (BJABXS vs BJABK1: mean = 68.0% vs 17.9%, difference = 50.1%, 95% CI = 43.4% to 56.8% [ P < .001], and mean = 73.9% vs 46.0%, difference = 27.9%, 95% CI = 14.4% to 41.4% [ P = .015], respectively) ( Figure 3, A ) . Next we explored protection from FasL-induced apoptosis in vivo. The recombinant FasL fused to Flag-tag and the cross-linking Flag antibody M2 were used to induce apoptosis in mouse livers ( 20 , 21 ) . Mice were transfected with vector control or with a K1-myc -expressing plasmid (n = 10 each group). Twentyfour hours after transfection, mice were injected with cross-linking antibody M2 alone (12.5 µ g per mouse), and half of each transfected group (n = 5) also received FasL-Flag (4 µ g per mouse). Six hours later, none of the vector-transfected, FasL + M2 crosslinking antibody-treated mice survived, whereas all of the K1-expressing mice and all control mice were alive ( P = .008) ( Figure 3, B ) . The livers from vector-transfected, FasL + M2 -treated mice were black with extensive hemorrhaging, but livers of M2 only -treated mice had normal color and appearance. The livers from K1-expressing, FasL + M2 -treated mice showed only limited patches of hemorrhage and no signs of extensive cell death ( Figure 3, C ) . Thus, these data show that K1 protects cells and mice from Fas-mediated apoptosis induced by both agonistic Fas antibody and FasL.
Inhibition of Binding of Activating Antibody and FasL to Fas by K1
Based on the results obtained thus far, we hypothesized that K1 would interfere with binding of agonistic antibody and FasL to Fas. To test this hypothesis, we first incubated BJABK1, BJABK1m, and BJABXS cells with the human Fas -activating antibody CH-11 ( 13 ) and analyzed the level of cell-bound CH-11 ( Figure 4, A , top panel) . After immunodepletion of CH-11 -bound Fas by precipitation with anti-mouse IgM antibody, cell extracts were probed for levels of remaining Fas ( Figure 4 , A , middle panel). Western blots clearly showed a lower amount of CH-11 associated with Fas in K1-and K1m-expressing cells (BJABK1 and BJABK1m, respectively) than in control cells (BJABXS), despite the fact that the cells had equal Fas levels in whole-cell extracts ( Figure 4, A ) and equal cell surface Fas levels ( Figure 4, B ) ( 13 ) . Moreover, the amount of Fas that remained in cell extracts after precipitation with CH-11 was inversely proportional to the amount of CH-11 in the first precipitation step ( Figure  4, A , middle panel) , further supporting the interference of K1 with binding of CH-11.
To determine whether K1 also interferes with binding of FasL to Fas, we incubated BJABK1, BJABK1m, and BJABXS cells with an excess of recombinant Flag-tagged FasL. After washing cells to remove unbound FasL, the amount of FasL bound to the cell surface was evaluated by immunoprecipitation with Flag antibody and Western blot ( Figure 4 , C ). In agreement with our hypothesis, the ability of K1-expressing cells (BJABK1) to bind FasL was decreased compared with control cells ( ( Figure 5, B ) . The GST pull-down assay showed that the ectodomain of K1 is sufficient to bind Fas ( Figure 5 , B , K1Ext-GST-AU1) and that an Ig-like domain is required for Fas binding ( Figure 5 , B , K1 ⌬ Ig-GST-AU1, arrowhead). To prove that the Ig-like domain alone is responsible for Fas binding, we transfected HEK 293 cells with K1 that had a deleted Ig-like domain (K1 ⌬ Ig). Immunoprecipitation and Western blot analysis revealed that proteins of the predicted sizes were expressed in transfected cells; however, K1 ⌬ Ig failed to associate with Fas ( Figure 5, C ) , confirming that the Ig domain is essential for the K1 -Fas interaction.
Next, we evaluated the ability of Fas-ectodomain deletion mutants to bind K1. We generated cumulative deletion mutants of the Fas-ectodomain that would preserve the formation of intramolecular disulfi de bonds between cysteines within each of the cysteine-rich domains (CRDs) of Fas ( Figure 6, A ) ( 28 ) . HEK 293 cells were cotransfected with plasmids that encoded HA-tagged Fas deletion mutants and with plasmid encoding full-length K1-Flag. Immunoprecipitation and Western blot analysis showed that all but the CRD3 deletion mutant coprecipitated with K1-Flag A ) The control BJABXS and K1-expressing BJABK1 cells were incubated with 0, 5, and 10 ng/mL of FasL. Twenty hours after treatment was started, cells were stained with Hoechst blue and apoptosis was evaluated based on nuclear morphology. Results represent the means and 95% confi dence intervals of three independent experiments, and P values were calculated using a two-sided Student t test for population comparisons. B ) Kaplan-Meier survival plot of C57B6 mice transfected with myc-tagged K1 (K1) or parental vector alone (vector). Twenty-four hours later, mice were treated with anti-Flag antibody M2 (12.5 µ g per mouse) alone or in combination with recombinant Flag-tagged Fas ligand (FasL, 4 µ g per mouse) and evaluated for survival for 7 hours. C ) Gross appearance of representative livers from vector and K1-transfected mice that were treated with crosslinking antibody M2 alone or in combination with FasL.
( Figure 6, B ) , suggesting a role for the ectodomain of Fas in formation of K1 -Fas complexes.
Requirement of the K1 Ig Domain in Protecting Mice From Lethal Challenge With Activating Fas Antibody
Thus far, we have shown that K1 expression protects mice from treatment with a lethal dose of agonistic Fas antibody and FasL by preventing Fas-mediated apoptosis of hepatocytes and that the K1 Ig -like domain is essential for K1 binding to Fas in vitro. In addition, it was reported previously ( 17 ) that the Ig-like domain of K1 is also required for K1 ITAM domain -mediated prosurvival signaling. Thus, in the next step, we aimed to prove the functional significance of the Ig domain -mediated K1 -Fas inhibitory complex and to determine whether signaling mediated through the K1 ITAM domain is required for inhibition of Fas-mediated apoptosis by K1 in vivo. Therefore, we transfected plasmids that expressed Flag-tagged full-length K1 (K1-Flag), K1 lacking the Ig-like domain (K1 ⌬ Ig-Flag), or K1 lacking the ITAM domain (K1m-Flag), or vector alone into mice and evaluated the survival of the mice after lethal treatment with agonistic Fas antibody Jo2, as described above. Although 7 of 10 (70%) K1-transfected mice and 4 of 4 (100%) K1m-transfected mice survived 6 hours after Jo2 treatment, none of the 6 K1 ⌬ Igtransfected mice survived ( Figure 7, A ) . The livers from K1-and K1m-transfected mice had a mostly normal tissue appearance and minimal hemorrhaging, whereas livers from K1 ⌬ Ig-transfected mice were swollen and hemorrhagic, similar to those of vectortransfected controls ( Figure 7 , B and C ). TUNEL staining ( Figure 7 , C ) revealed that K1 ⌬ Ig-transfected livers had similar percentages of apoptotic cells as vector controls but statistically significantly more apoptotic cells than K1-transfected mice (K1 ⌬ Ig vs K1: mean = 76.4% vs 34.2%, difference = 42.2%, 95% CI = 33.0% to 51.4%; P = .006). However, the percentage of apoptotic cells in K1m-transfected livers was comparable to that of K1-transfected livers and was statistically significantly lower than vector controls (K1m vs vector: mean = 36.1% vs 83.7%, difference = 47.6%, 95% CI = 35.5% to 59.6%; P = .008). 6 cells) were incubated with 1 µ g/mL of the human Fas agonistic agonistic CH-11 antibody for 10 minutes, and control BJAB cells were incubated with buffer alone. Excess antibody was removed, and cell extracts were immunoprecipitated (IP) with agarose-conjugated anti-IgM antibody and analyzed by Western blot (IB) to determine the amount of bound CH-11 ( top ). Remaining extracts ( arrow ) were immunoprecipitated and analyzed by Western blots using anti-Fas antibody B-10 to determine the amount of Fas that did not bind CH-11 ( middle ). In a parallel experiment, cell lysates of cells not treated with CH-11 were precipitated and Western blotted with B-10 antibody to detect total Fas ( bottom ). Anti-CD40 antibody was used as control. B ) BJABXS, BJABK1m, and BJABK1 cells (1.0 × 10 6 cells) were washed and incubated with allophycocyanin (APC)-conjugated nonactivating anti-Fas antibody for 20 minutes at 4°C. After washing to remove unbound antibody, cell were analyzed by fl ow cytometry to evaluate the levels of cells surface -localized Fas. C ) BJABXS, BJABK1m, and BJABK1 cells (1.0 × 10 6 cells) were incubated with 1 µ g/mL of FasLFlag for 10 minutes, and control BJAB cells were incubated with buffer alone. Excess FasL was removed, and cell extracts were immunoprecipitated with agarose-conjugated anti-Flag antibody and analyzed by Western blot to determine the amount of bound FasL (top). In a parallel experiment, cell lysates were Western blotted with B-10 antibody to detect total Fas (bottom). Anti-hemagglutinin (HA) tag antibody was used as control. The blots are representative images of three different experiments with similar results. These in vivo results broaden our conclusion from the in vitro studies ( Figure 5 , B and C ), indicating that the Ig-like domain of K1 is required for the association of K1 with Fas and is essential for K1-mediated protection from Fas-induced apoptosis ( Figure 7 ) . Moreover, the ITAM domain -lacking mutant K1m, which does not stimulate prosurvival signaling through Akt, is still able to protect against Fas-mediated apoptosis, indicating that cell survival control through Fas is ITAM independent in these settings.
Discussion
We previously implicated HHV-8 protein K1 in the modulation of Fas-mediated apoptosis ( 13 ) . The current results show that the HHV-8 protein K1 physically associates with Fas and thereby disrupts initiation of Fas-mediated apoptotic signaling induced by agonistic antibodies and FasL. Through the expression of K1 extracellular domain deletion mutants we mapped the relative domains required for K1 -Fas binding to their ectodomains and further defined the binding domain of K1 to be the Ig-like domain. Fas binding to K1 does not require the Fas PLAD (amino acids 1 -66), which is essential for Fas oligomerization and ligand binding ( 19 ) , but we narrowed it down to CRD3, a domain previously shown to bind agonistic Fas antibody CH-11, which maps to between Fas amino acids 110 and 119 within the CRD3 domain ( 29 ) . A more detailed mapping of the K1-interacting domain of Fas is complicated by the complex folding of the Fas extracellular domain, which is defined by nine disulfide bridges ( 28 ) , and deletions within the CRD domains lead to misfolding and aggregation of Fas, making further assessment difficult. The in vivo experiments confirmed that the Ig-like domain of K1 is required for protection of mice from a lethal treatment with agonistic Fas antibody (the amino acid sequences of mouse and human Fas have 78% homology) and that the ITAM-lacking K1 mutant retained its ability to protect against Fas-mediated apoptosis. The size of the cross-linked K1 -Fas complex (approximately 85 kDa) and interference with binding of agonistic antibody and FasL to Fas strongly suggest direct K1 binding to Fas; however, contribution of a mediator present in complexes with higher molecular weight (>250 kDa) cannot be ruled out.
Viral proteins, especially those produced by herpesviruses, mimic or directly target critical cellular regulatory proteins, particularly those involved in apoptotic signaling that threaten survival of infected cells ( 30 ) . The viral analogs of cellular proteins are usually well conserved among members of the herpesvirus families ( 31 ) . Surprisingly, the K1 gene of HHV-8 shows unusually high diversity in its extracellular domain. The sequence variability of K1 suggests the existence of a strong selective pressure that is proposed to be due to interaction with a host component that is variable in the human population ( 31 ) . Thus far, K1 has been known to interact with host proteins such as the µ -chain of the B-cell antigen receptor ( 32 ) and, now, the death signaling receptor Fas. Through both of these interactions, K1 promotes prosurvival effects. The interaction of K1 with the µ -chain of the B-cell antigen receptor interferes with the assembly of receptor subunits, which prevents receptor localization to the plasma membrane ( 32 ) . Missing prosurvival signaling that is mediated by the activated B-cell antigen receptor ITAM domain is replaced by constitutive signaling of the ITAM domain of K1 ( 10 -12 ) . K1 binding to Fas does not interfere with Fas localization to the cell membrane ( 13 ) but rather blocks binding of agonistic antibody and FasL to Fas ( Figure 4 ) . Thus, K1 can provide cells with a survival advantage at two levels: through activation of prosurvival signaling by its ITAM domain ( 10 -12 ) and through inhibition of proapoptotic signaling by the association of its Ig-like domain with Fas, which is ITAM independent. Inhibition of Fas-mediated apoptosis by K1 leads to deregulation of normal lymphocyte turnover, which may explain the suppression of apoptosis in lymphocytes and the development of lymph node hyperplasia, splenomegaly, and lymphoma in K1 transgenic mice ( 4 , 9 ) .
Fas-mediated apoptosis signaling is being increasingly recognized as having a major role in regulating the death of many cell types and is a particularly important defect in cancers. A minority of tumors shows resistance to apoptosis that is attributable to mutations of Fas or FasL or overexpression of caspase Ϫ 8(FLICE) -like inhibitory protein (cFLIP), which blocks Fas signaling. Also, Fas expression and apoptosis are highly susceptible to regulation and are enhanced by treatment with agents such as interferon-␥ , CD40 ligand, and rituximab ( 33 ) , which are believed to be effective mainly through the sensitization of cells to Fas-mediated apoptosis ( 34 -37 ) .
The high prevalence of resistance to Fas-mediated apoptosis in cancers despite common and normal expression of wild-type Fas receptors suggests the existence of yet unrecognized Fas inhibitors or modulators ( 23 , 34 , 38 , 39 ) . The CD44 isoforms v6 and v9 have been implicated in binding to and regulating Fas ( 39 , 40 ) . The hepatocyte growth factor receptor (HGFR/Met) was shown to bind Fas and to block Fas signaling ( 23 , 41 ) . On binding of hepatocyte growth factor, inhibition of Fas by HGFR/Met was released, and Fas signaling was restored ( 23 ) . The Fas-binding domain of HGFR/Met has yet to be identifi ed, but interestingly, the extracellular stem region of HGFR/Met is formed by four Ig domains ( 42 ) . Moreover, Toso, a protein that is expressed exclusively in hematopoietic cells, was shown to specifi cally interfere with Fasmediated activation of caspase-8 in activated T cells through its Ig domain ( 43 ) . Based on these data we speculate that K1, HGFR/ Met, and Toso may represent a new family of Fas inhibitors that associate with Fas through their Ig domains and thus interfere with the immediate early steps of Fas-mediated apoptotic signaling ( Table 1 ) .
Our study has some limitations. Although these results strongly support the notion of a causal relationship between HHV-8 protein K1 and lymphoma, one has to keep in mind that we observed apoptotic regulation in a system in which K1 was overexpressed outside the context of a virus-infected cell. Data showing K1 expression in tumors have not been readily available in part because K1 has a highly variable protein sequence. Despite this complication, we and others have shown spontaneous K1 mRNA and protein expression in HHV-8 -infected cells, in Kaposi sarcoma tumors, and during viral lytic phase in other tumor types ( 8 , 13 ) . The binding and blocking effect of K1 on Fas could be a nonspecifi c effect of K1 overexpression; however, this interaction occurs through a recognized binding domain, and selective inhibition of Fas signaling was detected in numerous cell types and in transgenic mice, which indicates a consistent role of K1 in the inhibition of apoptosis.
In conclusion, we have further delineated the mechanism of K1 in regulation of apoptosis. We confi rmed that K1 specifically blocks Fas-mediated apoptosis ( 13 ) 
